PATIENTS AND METHODS
Sixty-three eyes from 63 patients were enrolled in this prospective, multicenter, nonrandomized, clinical trial including four sites within Germany: Heidelberg (n=25), Duisburg (n=21), Mannheim (n=16), and Munich (n=1). The study protocol was approved by the ethics committee of the University of Heidelberg, Germany. All patients were informed about the nature of the study and gave written informed consent prior to enrollment. Inclusion criteria for the study were presbyopia with a minimum near add of ϩ2.00 diopters (D) at 40-cm distance to achieve best possible near visual acuity, hyperopia between 0.50 and 1.25 D, cylinder р0.50 D, no prior ocular surgery or any ocular pathology, corrected distance visual acuity (CDVA) of at least 20/25, and Scheimpfl ug corneal thickness of at least 500 μm (thinnest point).
Examinations were performed preoperatively as well as 1 day, 1 week, and 1, 3, 6, and 12 months postoperatively with the following parameters: uncorrected distance visual acuity (UDVA), CDVA, uncorrected near visual acuity (UNVA), distance-corrected near visual acuity (DCNVA), and corrected near visual acuity (CNVA). All near reading tests were performed at a fi xed distance of 40 cm from the treated eye using Sloan ETDRS near charts (Precision Vision, La Salle, Illinois). Additionally, detailed slit-lamp examinations including digital photograph as well as corneal topographies preoperatively and 3, 6, and 12 months postoperatively (Pentacam; Oculus Optikgeräte GmbH, Wetzlar, Germany) were performed. A questionnaire was used to analyze subjective satisfaction.
In addition, a subgroup of patients at one study site (n=22) was analyzed with a Hartmann-Shack aberrometer (Ocular Wavefront Analyzer; SCHWIND eye-techsolutions, Kleinostheim, Germany) preoperatively as well as 12 months postoperatively.
The preoperative examination was performed within 30 days prior to INTRACOR treatment. All patients were treated in their nondominant eye. Dominance/ nondominance of the eyes was determined using the hole-in-the-card test and pointing test. On the day of surgery, eyes were anesthetized using oxybuprocaine hydrochloride 0.4% eye drops. Under the surgical microscope, the line of sight was marked using the fi rst Purkinje image of a red fi xation light, on which the patient was asked to fi xate, to center the laser treatment and a suction ring was placed on the eye. Subsequently, the eye was connected to the femtosecond laser using a specifi c curved patient interface device and fi ve consecutive rings around the marked line of sight were cut with the laser beam purely intrastromally with a distance of approximately 100 μm to the corneal surface. The exact depth of these cuts, energy used, and spacing follows a proprietary nomogram, which is based, among other parameters, on pachymetry data. The treatment time was between 15 and 20 seconds in all cases.
Postoperatively, patients received dexamethasone 1% eye drops fi ve times a day and artifi cial tears as needed. The steroid eye drops were discontinued after 1 week.
The Kolmogorov-Smirnov test revealed that the parameters investigated were not normally distributed (PϽ.01) and the paired Wilcoxon test was applied. A P value Ͻ.05 indicated a statistically signifi cant difference. 
RESULTS

Median
REFRACTION
Refraction and visual acuity analysis revealed stable postoperative fi ndings from 1 to 3 months up to 1 year after surgery with only minimal variations over time.
Median preoperative distance spherical equivalent was ϩ0.63 D with a median sphere of ϩ0.75 D and median cylinder of 0.25 D. The INTRACOR treatment induced a median myopic shift of Ϫ0.50 D regarding the spherical equivalent, which is mainly due to sphere changes compared to stable cylinder values (Table 1) . This development was seen 1 month after surgery and did not show any further progression over time.
DISTANCE VISUAL ACUITY
No difference was noted regarding median UDVA of 0.1 logMAR before and 1 year after surgery (Table 2) . Some eyes showed a slight improvement due to the myopic refraction shift closer to zero (emmetropia)-12 months after surgery, 32.8% of eyes achieved 20/20 or better compared to 22.2% before treatment (Fig 1) . Regarding loss and gain of UDVA, 43.1% of eyes gained one or more lines, 24.1% were unchanged, and 32.7% lost one or more lines (Fig 2) . No statistically signifi cant difference was found (Wilcoxon test, PϾ.5).
Median CDVA remained stable for most eyes (Wilcoxon test, PϾ.2), 0.0 logMAR pre-and postoperatively ( Table 2 ). All (100%) eyes achieved 20/40 or better (Fig 3) . Regarding loss and gain of CDVA, 25% of eyes gained one to three lines, 21.4% lost one line, and 7.1% lost two lines (Fig 4) .
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NEAR VISUAL ACUITY
Median UNVA improved from 0.7 to 0.2 logMAR 1 year after treatment (Table 2) . Snellen visual acuity of 20/40 or better was achieved in 70.7% of eyes compared to only 3.2% preoperatively (Fig 5) . One year after surgery, all eyes gained UNVA, with a median of four lines; 3.4% achieved a gain of nine lines (Fig 6) .
Median DCNVA improved from 0.6 to 0.2 logMAR (Table 2) , with 75% of eyes achieving 20/40 or better and 89.3% 20/50 or better (Fig 7) . One (1.8%) eye lost one line, two (3.6%) eyes neither lost nor gained lines, and 53 (94.6%) eyes gained between one and nine lines (median: 3 lines) (Fig 8) . This gain in UNVA and DCNVA was statistically signifi cant (Wilcoxon test, PϽ.01).
Median CNVA was 0.0 logMAR before and 12 months after surgery (Wilcoxon test, PϾ.1). Corrected near visual acuity of 20/25 was achieved in 93.4% of eyes and 20/40 or better in 100% of eyes after treatment (Fig 9) . Regarding gains and losses of CNVA, 26.2% of eyes gained between one and three lines, 29.5% lost one line, and 11.5% lost two lines (Fig 10) . INTRACOR 1-year Results/Holzer et al tween 3 and 6 months was not signifi cant (P=.622), and the change between 6 and 12 months was signifi cant (P=.037). Median anterior corneal asphericity (Q-value at 6 mm) changed from Ϫ0.17 (range: Ϫ0.69 to 0.32) preoperatively to Ϫ0.21 (range: Ϫ0.73 to 0.15) at 3 months, Ϫ0.20 (range: Ϫ0.73 to 0.07) at 6 months, and Ϫ0.18 (range: Ϫ0.94 to 0.12) at 12 months postoperatively. The change between pre-and 12 months postoperative was statistically signifi cant (P=.002), but no signifi cant change was noted between 3 and 6 or between 6 and 12 months postoperative (P=.113 and P=.966, respectively).
Median posterior corneal asphericity (Q-value at 6 mm) changed from Ϫ0.30 (range: Ϫ0.71 to 0.09) preoperatively to Ϫ0.41 (range: Ϫ1.15 to Ϫ0.07) at 3 months, Ϫ0.41 (range: Ϫ1.01 to 0) at 6 months, and Ϫ0.43 (range: Ϫ1.18 to Ϫ0.02) at 12 months postoperatively.
The change between pre-and 12 months postoperative was highly statistically signifi cant (PϽ.001) whereas the change between 3 and 6 months was not (P=.126) and between 6 and 12 months was less significant (P=.03).
ABERROMETRY
The aberrometry measurements at one study site (22 eyes pre-and 21 eyes postoperatively) revealed a signifi cant change (P=.031) in spherical aberrations induced by the INTRACOR procedure. Measured for a 6-mm pupil size, the median spherical aberrations were reduced from 0.202 μm (range: 0.084 to 0.627 μm) preoperatively to 0.111 μm (range: 0.007 to 0.576 μm) 12 months postoperatively.
SUBJECTIVE QUESTIONNAIRE
Twelve months after surgery, 58 patients answered different questions regarding subjective satisfaction and visual acuity perception as well as photopic phenomena either on a scale from 0 to 4 or with "yes," "no," or "uncertain," respectively.
The median scores for glare and halos were 1.14 and 1.03, respectively, indicating a low perception of photopic phenomena. Noticeable vision problems (score Ͼ2.5) in dim light conditions were noted by 17.2% preoperatively vs 32.8% 12 months after surgery. Overall, 71.4% of patients were satisfi ed with 
2 4 3
Cumulative % of Eyes INTRACOR 1-year Results/Holzer et al the procedure, 19.6% were not, and 9% were uncertain (2 of 58 patients did not answer this question). In regards to undergoing the same procedure, 86% of patients would undergo treatment again whereas 12.3% answered "no" and 1.8% were uncertain (1 patient did not answer this question). In regards to treatment, 80.4% would recommend the procedure to a relative or friend, 16% would not, and 3.6% were uncertain (2 patients did not answer).
DISCUSSION
Corneal presbyopia correcting procedures include excimer laser treatments either as monovision procedures or as multifocal corneal ablations and conduc- 3,5,7,18-24 Laser in situ keratomileusis for myopic astigmatism and presbyopia using nonlinear, aspheric, micromonovision provided stable and effective results with 96% of eyes achieving binocular UNVA of J2. 23 Treating hyperopic astigmatism and presbyopia with this approach, Reinstein et al 24 reported 81% of patients could read J2 and 100% J5. Binocularly, 95% of patients achieved 20/20 and could read J5. No eyes lost two or more lines and contrast visual acuity was improved. 24 Epstein and Gurgos 19 found peripheral presbyLASIK in the nondominant eye with distance-directed monofocal refractive surgery in the dominant eye a valuable option. With regards to hyperopic patients treated, 71.4% achieved UNVA of at least 20/20 at 40 cm and 89% reported complete spectacle independence. 19 Pinelli et al 22 published their fi ndings regarding a center distance, paracentral near treatment of presbyopia and mild hyperopia up to ϩ3.00 D with a mean binocular uncorrected visual acuity of 1.06 for distance and 0.84 for near. In regards to CDVA, 4.5% of eyes lost one line. 22 Another multizone LASIK investigation using a center far algorithm was safe; however, only 33% of treated hyperopic patients achieved UNVA of 20/40 or better. Two percent of eyes lost two lines of CDVA and patients were satisfi ed in 54% of cases. 18 In contrast to these excimer laser methods, the femtosecond laser offers the advantage of keeping the corneal surface intact and reducing the risk of microbial infections. Aside from the INTRACOR procedure to correct presbyopia clinically, 17, 25 experimental studies on regaining lenticular elasticity by treating the crystalline lens have been evaluated. 26 The laser-induced biomechanical response of the cornea, which subsequently leads to the refractive effect, mostly manifests itself in the fi rst hours after surgery. The cut pattern induces a corneal curvature change with a central steepening with reduced spherical aberrations after surgery. The present multicenter trial has shown stable functional results 1 year after surgery. At least 20/40 uncorrected visual acuity was achieved by 94.8% of eyes regarding distance and 70.7% for near. All (100%) eyes gained near visual acuity; however, a wide distribution between one and nine lines was noted. The fact that some eyes only gained one to three lines indicates a certain number of "low-responders." To date, no factors, such as preoperative keratometry or corneal thickness as well as ring centration, have been found to have an impact on the predictability of the postoperative refractive result.
No patient lost more than two lines of CDVA and no adverse events related to the procedure have been reported. Regarding CDVA and CNVA, 100% of eyes achieved 20/40 or better. However, a loss of two lines of CDVA occurred in 7.1% of patients. Patients also reported slight but noticeable vision problems in dim light conditions with low perception of photopic phenomena and limited near visual acuity in dim light conditions. As with many other presbyopia correction procedures, the improvement of near vision sometimes involves a compromise, which needs to be discussed and explained to the patient prior to treatment.
The preoperative manifest refraction is important in patient selection. The current recommendation of the manufacturer (Technolas) includes a minimum spherical equivalent of ϩ0.25 D (sphere between ϩ0.50 and ϩ1.00 D and cylinder between 0.50 and 0.0 D). To achieve spectacle independence for distance and near, the myopic shift of approximately Ϫ0.50 D that can be seen in the majority of patients must be taken into account. 25 In this regard, it is highly recommended to also measure distance refraction after pharmacologic cycloplegia to detect cases of higher hyperopia. Furthermore, the myopic shift should be simulated either with glasses or contact lenses preoperatively.
Further aspects that need to be investigated in the future are different INTRACOR patterns to correct low degrees of myopia and astigmatism. The outcomes of binocular treatment are of interest to determine whether the refractive outcome can be further improved. Longer follow-up is needed to confi rm the continuous stability of functional results as well as corneal integrity. Further studies are necessary that evaluate the feasibility and outcomes of retreatment patterns in patients who gained insuffi cient near visual acuity after the initial surgery.
The femtosecond laser offers a variety of new treatment possibilities in many fi elds of ophthalmic anterior segment surgery. [27] [28] [29] [30] [31] With regards to presbyopia correction, the intrastromal INTRACOR procedure signifi cantly improved UNVA in most patients with only a few side effects. It presents an interesting option for the treatment of presbyopia. 
